Systemic treatment of patients with advanced cutaneous squamous cell carcinoma: response rates and outcomes of the regimes used.

•There are limited prospective studies on systemic therapy for advanced cutaneous squamous cell carcinoma.•Cisplatin-based chemotherapy is not always superior to other drugs.•RCT improves overall survival in patients with nodal squamous cell carcinoma.